Should We or Should We Not Reuse Filtering Face Piece Masks? A Review
نویسندگان
چکیده
منابع مشابه
Should we stay or should we go?
With the potential benefit of positive movement in the housing market and now having two properties this may place you in a good position to increase your retirement nest egg if you choose to sell your family home when you downsize. Depending on your situation you may even be able to keep the family home as an investment. One of the biggest decisions for many retirees is whether to stay in the ...
متن کاملIgA deficiency: what we should-or should not-be doing.
Although IgA deficiency (IgAD) is currently recognised as the most frequent immunodeficiency in humans, individuals with IgAD are largely considered to be healthy and when discovered are usually not investigated further or followed up. The rare occasion when IgAD is a cause for concern is when these individuals require blood or blood products, in which case current practice advises that product...
متن کاملShould we perform polypectomy or not?
Hong Kong Med J ⎥ Volume 20 Number 4 ⎥ August 2014 ⎥ www.hkmj.org A 78-year-old woman, with a known history of rheumatoid arthritis, complained of dizziness and was found to have iron-deficiency anaemia with a haemoglobin level of 105 g/L in January 2013. She was on treatment with methotrexate, sulphasalazine, and non-steroidal anti-inflammatory medications. Oesophagogastroduodenoscopy performi...
متن کاملNewborn resuscitation: should we oxygenate or not?
HOW SHOULD WE OXYGENATE newborn and infants suffering from hypoxia and ischemia? Is it harmful to use 100% O2? It may seem odd to question a practice that has been carried out for so long, seemingly without any adverse effects. The case is, however, that after the practice of routinely using 100% O2 for newborn resuscitation was examined, many serious potentially harmful effects have to date be...
متن کامل“How should we treat older patients with Metastatic Colorectal Cancer, A Review”
Nearly 50 % of newly diagnosed colorectal cancer, affect people over 70 years of age. Inclusion of older patients in clinical trials has been extremely rare. As a result, there is debate on how to manage these patients because it is still unclear how to balance the therapeutic advantages and toxicities. For patients who do not have comorbid conditions, with performance status (P.S.) 0–1, treatm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Critical Care Medicine
سال: 2020
ISSN: 0972-5229,1998-359X
DOI: 10.5005/jp-journals-10071-23565